Find Scholarly Works

Search in all content

Filters for Scholarly Works

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

Author

  • Keith Lindor
2011

Current therapies for nonalcoholic fatty liver disease

Gossard, A. A. & Lindor, K. D., Dec 1 2011, In : Drugs of Today. 47, 12, p. 915-922 8 p.

Research output: Contribution to journalReview article

20 Scopus citations
2016

Ursodeoxycholic acid treatment in primary sclerosing cholangitis

Tabibian, J. H. & Lindor, K., Jan 1 2016, Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Developments. Springer International Publishing, p. 145-152 8 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2015

Recurrence of primary sclerosing cholangitis after liver transplantation

Charatcharoenwitthaya, P. & Lindor, K., Jan 1 2015, Disease Recurrence After Liver Transplantation: Natural History, Treatment and Survival. Springer New York, p. 121-134 14 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2014

Ursodeoxycholic acid in primary sclerosing cholangitis: If withdrawal is bad, then administration is good (right?)

Tabibian, J. H. & Lindor, K., Sep 2014, In : Hepatology. 60, 3, p. 785-788 4 p.

Research output: Contribution to journalArticle

26 Scopus citations
2016

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Hepatology. 64, 4, p. 1031-1032 2 p.

Research output: Contribution to journalEditorial

4 Scopus citations
2011

The value of observational research in liver diseases

Lindor, R. A. & Lindor, K. D., Jan 1 2011, In : Hepatology. 53, 1, p. 1-3 3 p.

Research output: Contribution to journalComment/debate

11 Scopus citations

Eyewitnesses to history and participants as well

Lindor, K. D., Dec 1 2011, In : Hepatology. 54, 6, 1 p.

Research output: Contribution to journalComment/debate

Reply

Lindor, R. A. & Lindor, K. D., Aug 1 2011, In : Hepatology. 54, 2, p. 740 1 p.

Research output: Contribution to journalLetter

2016

Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis

Hilscher, M., Enders, F. B., Carey, E. J., Lindor, K. & Tabibian, J. H., Mar 1 2016, In : Annals of Hepatology. 15, 2, p. 246-253 8 p.

Research output: Contribution to journalArticle

25 Scopus citations
2020

Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis

FOLD Investigators, Feb 1 2020, In : The American journal of gastroenterology. 115, 2, p. 262-270 9 p.

Research output: Contribution to journalArticle

2013

Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis

Imam, M. H., Thackeray, E. W. & Lindor, K. D., Feb 1 2013, In : Colorectal Disease. 15, 2, p. 198-203 6 p.

Research output: Contribution to journalArticle

9 Scopus citations
2015

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 2015, In : Gut. 64, 11, p. 1671-1672 2 p.

Research output: Contribution to journalShort survey

22 Scopus citations
2019

Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry

Kuo, A., Gomel, R., Safer, R., Lindor, K., Everson, G. T. & Bowlus, C. L., Jun 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 7, p. 1372-1378 7 p.

Research output: Contribution to journalArticle

2 Scopus citations
2014

Foreword

Lindor, K., Jan 1 2014, In : Unknown Journal. p. vii-viii

Research output: Contribution to journalArticle

2015

Docetaxel Induced Sclerosing Cholangitis

Horsley-Silva, J. L., Dow, E. N., Menias, C. O., Smith, M. L., Carballido, E. M., Lindor, K. D. & Vargas, H. E., Dec 1 2015, In : Digestive Diseases and Sciences. 60, 12, p. 3814-3816 3 p.

Research output: Contribution to journalArticle

8 Scopus citations
2011

Pregnancy in primary sclerosing cholangitis

Gossard, A. & Lindor, K., Aug 1 2011, In : Gut. 60, 8, p. 1027-1028 2 p.

Research output: Contribution to journalComment/debate

2 Scopus citations
2014

Association of adiposity, measures of metabolic dysregulation, and elevated alanine aminotransferase in subjects with normal body mass index

Treeprasertsuk, S., Romero-Corral, A., Somers, V. K., Sierra-Johnson, J., Lindor, K. D., Angulo, P. & Lopez-Jimenez, F., Oct 1 2014, In : Asian Biomedicine. 8, 5, p. 585-595 11 p.

Research output: Contribution to journalArticle

2015
2 Scopus citations
2017

Combination therapy of all-trans retinoic acid with ursodeoxycholic acid in patients with primary sclerosing cholangitis: A human pilot study

Assis, D. N., Abdelghany, O., Cai, S. Y., Gossard, A. A., Eaton, J. E., Keach, J. C., Deng, Y., Setchell, K. D. R., Ciarleglio, M., Lindor, K. & Boyer, J. L., Jan 1 2017, In : Journal of Clinical Gastroenterology. 51, 2, p. e11-e16

Research output: Contribution to journalArticle

16 Scopus citations
2011

Pilot study: Fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

Levy, C., Peter, J. A., Nelson, D. R., Keach, J., Petz, J., Cabrera, R., Clark, V., Firpi, R. J., Morelli, G., Soldevila-Pico, C. & Lindor, K., Jan 1 2011, In : Alimentary Pharmacology and Therapeutics. 33, 2, p. 235-242 8 p.

Research output: Contribution to journalArticle

97 Scopus citations

Parenteral bisphosphonates for osteoporosis in patients with primary biliary cirrhosis

Treeprasertsuk, S., Silveira, M. G., Petz, J. L. & Lindor, K. D., Sep 1 2011, In : American Journal of Therapeutics. 18, 5, p. 375-381 7 p.

Research output: Contribution to journalArticle

12 Scopus citations

A model for integration of formal knowledge and clinical experience: The Advanced Doctoring course at Mayo Medical School

Dyrbye, L. N., Starr, S. R., Thompson, G. B. & Lindor, K. D., Sep 2011, In : Academic Medicine. 86, 9, p. 1130-1136 7 p.

Research output: Contribution to journalArticle

9 Scopus citations

Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma

Fritcher, E. G. B., Kipp, B. R., Voss, J. S., Clayton, A. C., Lindor, K. D., Halling, K. C. & Gores, G. J., Nov 1 2011, In : American Journal of Gastroenterology. 106, 11, p. 2023-2028 6 p.

Research output: Contribution to journalArticle

74 Scopus citations
2012

Primary sclerosing cholangitis: Providing a safe and effective treatment

Imam, M. H. & Lindor, K. D., Jun 1 2012, In : Expert Review of Gastroenterology and Hepatology. 6, 3, p. 255-257 3 p.

Research output: Contribution to journalReview article

2015

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Oct 1 2015, In : Clinics and Research in Hepatology and Gastroenterology. 39, 5, p. e57-e59 800.

Research output: Contribution to journalComment/debate

20 Scopus citations
2011

Leader's portrait

Lindor, K. D., 2011, In : Clinics and Research in Hepatology and Gastroenterology. 35, 6-7, p. 423-425 3 p.

Research output: Contribution to journalEditorial

2016

Advances in primary sclerosing cholangitis

Horsley-Silva, J. L., Carey, E. J. & Lindor, K., 2016, In : The Lancet Gastroenterology and Hepatology. 1, 1, p. 68-77 10 p.

Research output: Contribution to journalReview article

11 Scopus citations
2018

Primary sclerosing cholangitis, part 1: Epidemiology, etiopathogenesis, clinical features, and treatment

Tabibian, J. H., Ali, A. H. & Lindor, K., May 1 2018, In : Gastroenterology and Hepatology. 14, 5, p. 293-304 12 p.

Research output: Contribution to journalArticle

7 Scopus citations
2016

Novel treatments in primary sclerosing cholangitis

Ali, A. H. & Lindor, K., Nov 1 2016, In : Clinical Liver Disease. 8, 5, p. 132-135 4 p.

Research output: Contribution to journalReview article

1 Scopus citations
2013

Inflammatory bowel disease in primary sclerosing cholangitis: A robust yet changing relationship

Sinakos, E., Samuel, S., Enders, F., Loftus, E. V., Sandborn, W. J. & Lindor, K. D., Apr 2013, In : Inflammatory Bowel Diseases. 19, 5, p. 1004-1009 6 p.

Research output: Contribution to journalArticle

28 Scopus citations
2019

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

the GLOBAL PBC Study Group, Nov 1 2019, In : Alimentary Pharmacology and Therapeutics. 50, 10, p. 1127-1136 10 p.

Research output: Contribution to journalArticle

Open Access
6 Scopus citations
2018

Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: Risk factors and time trends in incidence and outcome

Harms, M. H., Lammers, W. J., Thorburn, D., Corpechot, C., Invernizzi, P., Janssen, H. L. A., Battezzati, P. M., Nevens, F., Lindor, K., Floreani, A., Ponsioen, C. Y., Mayo, M. J., Dalekos, G. N., Bruns, T., Parés, A., Mason, A. L., Verhelst, X., Kowdley, K. V., Goet, J. C., Hirschfield, G. M. & 2 others, Hansen, B. E. & Van Buuren, H. R., Feb 1 2018, In : American Journal of Gastroenterology. 113, 2, p. 254-264 11 p.

Research output: Contribution to journalArticle

24 Scopus citations
2019

Current and promising therapy for primary biliary cholangitis

Gossard, A. A. & Lindor, K., Jun 13 2019, In : Expert Opinion on Pharmacotherapy. 20, 9, p. 1161-1167 7 p.

Research output: Contribution to journalReview article

3 Scopus citations
2011

B cell depletion therapy exacerbates murine primary biliary cirrhosis

Dhirapong, A., Lleo, A., Yang, G. X., Tsuneyama, K., Dunn, R., Kehry, M., Packard, T. A., Cambier, J. C., Liu, F. T., Lindor, K., Coppel, R. L., Ansari, A. A. & Gershwin, M. E., Feb 2011, In : Hepatology. 53, 2, p. 527-535 9 p.

Research output: Contribution to journalArticle

56 Scopus citations

Current management of primary sclerosing cholangitis in pediatric patients

Ibrahim, S. H. & Lindor, K. D., Mar 7 2011, In : Pediatric Drugs. 13, 2, p. 87-95 9 p.

Research output: Contribution to journalReview article

25 Scopus citations
2012

The Framingham risk score and heart disease in nonalcoholic fatty liver disease

Treeprasertsuk, S., Leverage, S., Adams, L. A., Lindor, K. D., St Sauver, J. & Angulo, P., Jul 1 2012, In : Liver International. 32, 6, p. 945-950 6 p.

Research output: Contribution to journalArticle

85 Scopus citations
2019

NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A nebulous matter

Tabibian, J. H. & Lindor, K., Jan 1 2019, (Accepted/In press) In : Journal of Hepatology.

Research output: Contribution to journalArticle

3 Scopus citations

Cancer risk, screening and surveillance in primary sclerosing cholangitis

Chascsa, D. M. & Lindor, K. D., Sep 1 2019, In : Minerva gastroenterologica e dietologica. 65, 3, p. 214-228 15 p.

Research output: Contribution to journalArticle

2 Scopus citations
2013

Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management

Eaton, J. E., Talwalkar, J. A., Lazaridis, K. N., Gores, G. J. & Lindor, K., Sep 2013, In : Gastroenterology. 145, 3, p. 521-536 16 p.

Research output: Contribution to journalReview article

209 Scopus citations
2011

Gender differences in academic productivity and leadership appointments of physicians throughout academic careers

Reed, D. A., Enders, F., Lindor, R., McClees, M. & Lindor, K. D., Jan 2011, In : Academic Medicine. 86, 1, p. 43-47 5 p.

Research output: Contribution to journalArticle

134 Scopus citations

The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury

Suzuki, A., Brunt, E. M., Kleiner, D. E., Miquel, R., Smyrk, T. C., Andrade, R. J., Isabel Lucena, M., Castiella, A., Lindor, K. & Björnsson, E., Sep 2 2011, In : Hepatology. 54, 3, p. 931-939 9 p.

Research output: Contribution to journalArticle

166 Scopus citations
2012

Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis

Momah, N., Silveira, M. G., Jorgensen, R., Sinakos, E. & Lindor, K. D., May 1 2012, In : Liver International. 32, 5, p. 790-795 6 p.

Research output: Contribution to journalArticle

38 Scopus citations
2014

Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study

Global PBC Study Group, Dec 1 2014, In : Gastroenterology. 147, 6, p. 1338-1349.e5

Research output: Contribution to journalArticle

172 Scopus citations
2012

Prevalence and Indicators of Portal Hypertension in Patients With Nonalcoholic Fatty Liver Disease

Mendes, F. D., Suzuki, A., Sanderson, S. O., Lindor, K. D. & Angulo, P., Sep 2012, In : Clinical Gastroenterology and Hepatology. 10, 9, p. 1028-1033.e2

Research output: Contribution to journalArticle

33 Scopus citations
2011

Cancer surveillance in patients with primary sclerosing cholangitis

Razumilava, N., Gores, G. J. & Lindor, K. D., Nov 1 2011, In : Hepatology. 54, 5, p. 1842-1852 11 p.

Research output: Contribution to journalReview article

173 Scopus citations

Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis

Stanich, P. P., Björnsson, E., Gossard, A. A., Enders, F., Jorgensen, R. & Lindor, K. D., Apr 1 2011, In : Digestive and Liver Disease. 43, 4, p. 309-313 5 p.

Research output: Contribution to journalArticle

104 Scopus citations
2015

Unmet clinical need in autoimmune liver diseases

Dyson, J. K., Webb, G., Hirschfield, G. M., Lohse, A., Beuers, U., Lindor, K. & Jones, D. E. J., Jan 1 2015, In : Journal of Hepatology. 62, 1, p. 208-218 11 p.

Research output: Contribution to journalReview article

40 Scopus citations
2016

Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study

PURIFI Study Group, Jul 1 2016, In : Hepatology. 64, 1, p. 189-199 11 p.

Research output: Contribution to journalArticle

52 Scopus citations
2017

Old and new treatments for primary biliary cholangitis

Chascsa, D., Carey, E. J. & Lindor, K., Apr 1 2017, In : Liver International. 37, 4, p. 490-499 10 p.

Research output: Contribution to journalArticle

21 Scopus citations
2019

Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

Harms, M. H., van Buuren, H. R., Corpechot, C., Thorburn, D., Janssen, H. L. A., Lindor, K. D., Hirschfield, G. M., Parés, A., Floreani, A., Mayo, M. J., Invernizzi, P., Battezzati, P. M., Nevens, F., Ponsioen, C. Y., Mason, A. L., Kowdley, K. V., Lammers, W. J., Hansen, B. E. & van der Meer, A. J., Aug 2019, In : Journal of Hepatology. 71, 2, p. 357-365 9 p.

Research output: Contribution to journalArticle

19 Scopus citations